Cannabics Pharmaceuticals Stock Fundamentals
| CNBX Stock | USD 0.01 0.00 0.00% |
Cannabics Pharmaceuticals fundamentals help investors to digest information that contributes to Cannabics Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Cannabics Pink Sheet. The fundamental analysis module provides a way to measure Cannabics Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannabics Pharmaceuticals pink sheet.
Cannabics |
Cannabics Pharmaceuticals Company Shares Outstanding Analysis
Cannabics Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cannabics Pharmaceuticals Shares Outstanding | 1.26 M |
Most of Cannabics Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabics Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cannabics Pharmaceuticals has 1.26 M of shares currently outstending. This is 99.3% lower than that of the Pharmaceuticals sector and 98.82% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.78% higher than that of the company.
Cannabics Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cannabics Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Cannabics Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannabics Pharmaceuticals competition to find correlations between indicators driving Cannabics Pharmaceuticals's intrinsic value. More Info.Cannabics Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cannabics Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cannabics Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Cannabics Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannabics Pharmaceuticals' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cannabics Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cannabics Pharmaceuticals by comparing valuation metrics of similar companies.Cannabics Pharmaceuticals is currently under evaluation in shares outstanding category among its peers.
Cannabics Fundamentals
| Return On Equity | -42.89 | |||
| Return On Asset | -1.0 | |||
| Current Valuation | 6.67 M | |||
| Shares Outstanding | 1.26 M | |||
| Shares Owned By Insiders | 57.59 % | |||
| Price To Earning | 31.09 X | |||
| Price To Book | 20.39 X | |||
| Price To Sales | 7,566 X | |||
| Gross Profit | 7.16 K | |||
| EBITDA | (3.52 M) | |||
| Net Income | (3.72 M) | |||
| Cash And Equivalents | 96.28 K | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 1.6 M | |||
| Debt To Equity | 0.48 % | |||
| Current Ratio | 0.11 X | |||
| Book Value Per Share | (1.57) X | |||
| Cash Flow From Operations | (1.68 M) | |||
| Earnings Per Share | (3.80) X | |||
| Beta | 1.52 | |||
| Market Capitalization | 123.28 K | |||
| Total Asset | 811.17 K | |||
| Z Score | -13.2 | |||
| Net Asset | 811.17 K |
About Cannabics Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannabics Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabics Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabics Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. Cnbx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cannabics Pink Sheet Analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.